PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12325046-5	2002	SPECT studies 4, 10, and 31 days after MDMA treatment revealed decreases in [123I]beta-CIT binding ratios in the SERT-rich brain region studied (hypothalamic/midbrain region), with SERT density reduced by 39% in this brain region 31 days after treatment.	2beta-carbomethoxy-3beta-(4-iodophenyl)tropane	82-90	solute carrier family 6 member 4	Rattus norvegicus	113-117	
23115651-3	2012	METHODS: 5-HT transporter (SERT) densities in the frontal cortex and midbrain were assessed with [(123)I]beta-CIT single photon emission computed tomography in 33 users of ecstasy.	2beta-carbomethoxy-3beta-(4-iodophenyl)tropane	105-113	solute carrier family 6 member 4	Rattus norvegicus	9-25	
23115651-3	2012	METHODS: 5-HT transporter (SERT) densities in the frontal cortex and midbrain were assessed with [(123)I]beta-CIT single photon emission computed tomography in 33 users of ecstasy.	2beta-carbomethoxy-3beta-(4-iodophenyl)tropane	105-113	solute carrier family 6 member 4	Rattus norvegicus	27-31	
19453722-7	2009	The interaction between CBZ and 125I beta-CIT binding to SERT and DAT was investigated using in vitro autoradiography.	2beta-carbomethoxy-3beta-(4-iodophenyl)tropane	37-45	solute carrier family 6 member 4	Rattus norvegicus	57-61	
12325046-7	2002	In addition, ex vivo [123I]beta-CIT binding studies in rats 1 week after treatment with neurotoxic doses of MDMA (20 mg/kg s.c. twice daily for 4 consecutive days) revealed significant reductions in [123I]beta-CIT binding in SERT-rich regions (including the hypothalamus) when compared to saline-treated rats.	2beta-carbomethoxy-3beta-(4-iodophenyl)tropane	27-35	solute carrier family 6 member 4	Rattus norvegicus	225-229	
12325046-8	2002	The combined results of these studies indicate that SPECT imaging of SERT with [123I]beta-CIT can detect changes in SERT density secondary to MDMA-induced neurotoxicity in the hypothalamic/midbrain region, and possibly other brain regions.	2beta-carbomethoxy-3beta-(4-iodophenyl)tropane	85-93	solute carrier family 6 member 4	Rattus norvegicus	69-73	
12325046-8	2002	The combined results of these studies indicate that SPECT imaging of SERT with [123I]beta-CIT can detect changes in SERT density secondary to MDMA-induced neurotoxicity in the hypothalamic/midbrain region, and possibly other brain regions.	2beta-carbomethoxy-3beta-(4-iodophenyl)tropane	85-93	solute carrier family 6 member 4	Rattus norvegicus	116-120	
11062247-2	2001	Specific binding of RTI-233 to the rat serotonin transporter, purified from Sf-9 insect cells, was demonstrated by the competitive inhibition of fluorescence using excess serotonin, citalopram, or RTI-55 (2beta-carbomethoxy-3beta-(4-iodophenyl)tropane).	2beta-carbomethoxy-3beta-(4-iodophenyl)tropane	197-203	solute carrier family 6 member 4	Rattus norvegicus	39-60	
11062247-2	2001	Specific binding of RTI-233 to the rat serotonin transporter, purified from Sf-9 insect cells, was demonstrated by the competitive inhibition of fluorescence using excess serotonin, citalopram, or RTI-55 (2beta-carbomethoxy-3beta-(4-iodophenyl)tropane).	2beta-carbomethoxy-3beta-(4-iodophenyl)tropane	205-251	solute carrier family 6 member 4	Rattus norvegicus	39-60	
9843724-0	1998	Relationship between [125I]RTI-55-labeled cocaine binding sites and the serotonin transporter in rat placenta.	2beta-carbomethoxy-3beta-(4-iodophenyl)tropane	27-33	solute carrier family 6 member 4	Rattus norvegicus	72-93	
1385663-1	1992	[123I]RTI-55, an iodinated derivative of the cocaine analog 3 beta-phenyltropane-2 beta-carboxylic acid methyl ester, was evaluated as an agent for in vivo labeling of the serotonin transporter.	2beta-carbomethoxy-3beta-(4-iodophenyl)tropane	6-12	solute carrier family 6 member 4	Rattus norvegicus	172-193